Compumedics Limited (ASX:CMP) is pleased to announce that the Company's German-­-based, brain blood-­-flow Doppler-sonography division, Compumedics Germany GmbH, has secured a AUD$375K deal to supply its Doppler-Box technology to key military hospitals in China.

Leading Australia-based medical device company, Compumedics Limited (ASX:CMP) is pleased to announce profitability and revenue growth for the half year ending 31 December 2014.

Regenerative medicine company, Regeneus Ltd (ASX:RGS) is pleased to announce the appointment of Dr Glen Richards as an independent non-executive director of Regeneus with effect from April.

Compumedics Limited (ASX:CMP) is pleased to announce it has executed a new export working capital guarantee facility with EFIC in conjunction with the ANZ Bank. This new facility will provide funding of up to USD$l.OM to enable the Company to continue to grow and develop its key export markets. The facility is complementary to Compumedics existing working capital facilities.

SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today its results for the first half year to December 2013. The company posted strong unit and revenue growth, generated profits and cash whilst continuing to invest in its future through its medical initiative and further acquisitions in both Europe and the APAC regions.

Alchemia Limited (ASX:ACL) a drug discovery and development company, is pleased to announce its half year results for the six months ended 31 December 2013.

SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today the expansion of its business in the Republic of Korea, following the registration by the Korean FDA of SomnoDent(R) as an accepted medical device for the treatment of obstructive sleep apnea.

Cyclopharm Limited (ASX:CYC) is an Australian-based company manufacturing and selling nuclear medicine equipment, radiopharmaceuticals and related research and development services. The company specializes in imaging of lungs (Technegas system) and molecular imaging radiopharmaceuticals used in cancer, brain and cardiac imaging.

Asian Activities Report for December 14, 2011 includes: Coach, Inc. (NYSE:COH) (HKG:6388) has opened its first official online store in China on Taobao Mall; Japan-based global IT giant NTT Data Corporation (TYO:9613) has opened a childcare centre, named "Egg Garden" at its headquarter in Toyosu, Koto-ku, Tokyo, Japan; Shiseido (TYO:4911) has announced its intent to sell bareMinerals makeup products in Brazil; Astellas Pharma Inc. (TYO:4503) and Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced that the European Commission has granted a marketing authorisation for DIFICLIR(TM) tablets for the treatment of adults aged 18 years and older with Clostridium difficile infections (CDI) in the European Union.

Asian Activities Report for October 11, 2011 includes: Allied Healthcare Group (ASX:AHZ) says today that its investee company Coridon Pty Ltd has successfully completed pre-clinical efficacy testing of its prototype Herpes Simplex Virus 2 vaccine with outstanding results; Universal Biosensors, Inc. (ASX:UBI) has commenced a new research and development project for Cilag GmbH International to determine the feasibility of an innovative blood glucose product to be used in the field of diabetes; Kalgoorlie Mining Company Limited (ASX:KMC) reports that recent drilling of the East Lode at the Bullant gold mine has intersected a spectacular high grade gold zone; Midas Resources Limited (ASX:MDS) will commence aircore drilling on a gold target south of the Intrepid Prospect at the Company's Lake Carey Project in Western Australia.